IGIB 📈 iShares 5-10 Year - Overview
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US4642886380 • Corporate Bond
IGIB: Bonds, Corporate, Debt, Securities, Futures, Options, Swaps
The iShares 5-10 Year Investment Grade Corporate Bond ETF, listed on NASDAQ under the ticker IGIB, is designed to track a specific index, with a minimum of 80% of its assets invested in the component securities of that index. This strategic allocation is intended to closely mirror the performance of the underlying index, providing investors with exposure to a diversified portfolio of investment-grade corporate bonds. By focusing on bonds with 5-10 year maturities, the fund offers a targeted approach to fixed income investing, which can be particularly appealing to investors seeking regular income and relatively lower risk.
Furthermore, the fund's investment strategy involves allocating at least 90% of its assets in fixed income securities that are of the types included in the underlying index. This approach is complemented by the ability to invest up to 10% of its assets in derivatives such as futures, options, and swaps contracts, as well as in other fixed income securities not included in the index, provided these investments are believed to enhance the fund's ability to track the index. This flexibility allows the fund manager, BFA, to employ a range of strategies to optimize the fund's performance and maintain its tracking efficiency. The fund is categorized as a corporate bond ETF, with the ISIN US4642886380, and is domiciled in the United States.
As an exchange-traded fund (ETF), IGIB offers the benefits of transparency, liquidity, and diversification, making it an attractive option for investors seeking to add a corporate bond component to their portfolios. The fund's investment grade focus ensures that it invests in bonds issued by companies with strong credit profiles, which can help mitigate default risk. By tracking an index of 5-10 year investment-grade corporate bonds, the fund provides a straightforward way for investors to gain exposure to this segment of the bond market, potentially benefiting from the regular income streams and the relatively lower volatility associated with investment-grade corporate bonds.
Additional Sources for IGIB ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IGIB ETF Overview
Market Cap in USD | 15,056m |
Category | Corporate Bond |
TER | 0.04% |
IPO / Inception | 2007-01-05 |
IGIB ETF Ratings
Growth 5y | 4.41% |
Fundamental | - |
Dividend | 55.2% |
Rel. Strength Industry | 152 |
Analysts | - |
Fair Price Momentum | 49.52 USD |
Fair Price DCF | - |
IGIB Dividends
Dividend Yield 12m | 4.02% |
Yield on Cost 5y | 4.21% |
Annual Growth 5y | -0.29% |
Payout Consistency | 92.5% |
IGIB Growth Ratios
Growth Correlation 3m | -44.6% |
Growth Correlation 12m | 83.1% |
Growth Correlation 5y | -35.8% |
CAGR 5y | 0.92% |
CAGR/Mean DD 5y | 0.13 |
Sharpe Ratio 12m | -0.19 |
Alpha | -7.71 |
Beta | 0.28 |
Volatility | 5.62% |
Current Volume | 1577.1k |
Average Volume 20d | 2271.6k |
As of December 27, 2024, the stock is trading at USD 51.55 with a total of 1,577,100 shares traded.
Over the past week, the price has changed by +0.43%, over one month by -0.79%, over three months by -2.46% and over the past year by +3.88%.
Neither. Based on ValueRay Analyses, iShares 5-10 Year is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 4.41 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IGIB as of December 2024 is 49.52. This means that IGIB is currently overvalued and has a potential downside of -3.94%.
iShares 5-10 Year has no consensus analysts rating.
According to ValueRays Forecast Model, IGIB iShares 5-10 Year will be worth about 53.8 in December 2025. The stock is currently trading at 51.55. This means that the stock has a potential upside of +4.4%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 53.8 | 4.4% |